Humacyte, Inc. (NASDAQ:HUMAW) Short Interest Up 133.3% in June

Humacyte, Inc. (NASDAQ:HUMAW) was the target of a significant increase in short interest in June. As of June 30th, there was short interest totalling 700 shares, an increase of 133.3% from the June 15th total of 300 shares. Based on an average daily volume of 33,500 shares, the days-to-cover ratio is presently 0.0 days.

Humacyte Price Performance

Shares of NASDAQ HUMAW opened at $2.18 on Friday. Humacyte has a 12 month low of $0.35 and a 12 month high of $3.29. The stock has a 50-day moving average price of $1.70 and a two-hundred day moving average price of $0.98.

Humacyte Company Profile

Humacyte, Inc engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection.